The impacts of vorinostat on NADPH oxidase and mitochondrial biogenesis gene expression in the heart of mice model of depression
Abstract
The comorbidity of depression and high risk of cardiovascular diseases (CVD) have been reported as major health problems. Our previous study confirmed that fluoxetine (FLX) therapy had a significant influence on brain function but not on the heart in depression. In the present study, suberoyanilide hydroxamic acid (SAHA) was proposed as another therapeutic candidate for treatment of depression comorbid CVD in maternal separation model, following behavioral analyses and gene expression level in the heart. Our data demonstrated that SAHA significantly attenuates the NOX-4 gene expression level in treated mice with SAHA and FLX without significant change in NOX-2 expression level. SAHA decreased the gene expression level of peroxisome proliferator-activated receptor-gamma coactivator (PGC-1α) and nuclear respiratory factors (Nrf2) in heart tissues of maternally separated mice. It supposed that non-effectiveness of FLX on mitochondrial biogenesis and NOX gene expression level in the heart of depressed patient can be related to recurrence of depression. It revealed that SAHA not only reversed the depressive-like behavior similar to our previous data but also recovered the heart mitochondrial function via effect on NOX-2, NOX-4, and mitochondrial biogenesis genes' (PGC-1 α, Nrf-2, and peroxisome proliferator-activated receptor- α (PPAR- α)) expression levels. We suggest performing more studies to confirm SAHA as a therapeutic candidate in depression comorbid CVD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The broad-spectrum HDAC inhibitor SAHA exhibits antidepressant effects across multiple animal models, with benefits that extend beyond mood improvement.
“The broad-spectrum HDAC inhibitor SAHA exhibits antidepressant effects across multiple animal models, with benefits that extend beyond mood improvement (Nasehi et al., 2022; Ershadi et al., 2021; Chen et al., 2019; Meylan et al., 2016).”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Nasehi et al., 2022
HDACs and HMTs regulate stress susceptibility, neural plasticity, cognitive function, and comorbid somatic conditions.
“Preclinical studies consistently show that HDACs and HMTs regulate stress susceptibility, neural plasticity, cognitive function, and comorbid somatic conditions (Li et al., 2024; Nasehi et al., 2022; Ershadi et al., 2021).”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Nasehi et al., 2022
Cites
Depression and cardiac mortality: results from a community-based longitudinal study.
Penninx, B., Beekman, A., Honig, A., Deeg, D., Schoevers, R., van Eijk, J., & van Tilburg, W. V. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.3.221 · Cited by 983 · see citing works
NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., & Sadoshima, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002178107 · Cited by 772 · see citing works
Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress
Lee, H., & Wei, Y. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.09.010 · Cited by 660 · see citing works
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. “. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 546 · see citing works
Rabinovitch, R. C., Samborska, B., Faubert, B., Ma, E. H., Gravel, S.-P., Andrzejewski, S., Raissi, T. C., Pause, A., St.-Pierre, J., & Jones, R. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.026 · Cited by 543 · see citing works
Prospects: Histone deacetylase inhibitors
Dokmanovic, M., & Marks, P. A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20532 · Cited by 480 · see citing works
Roceri, M., Hendriks, W. J. A. J., Racagni, G., Ellenbroek, B. A., & Riva, M. A. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001036 · Cited by 465 · see citing works
Control of Cardiac Growth by Histone Acetylation/Deacetylation
Backs, J., & Olson, E. N. (2006) · Circulation Research · doi:10.1161/01.res.0000197782.21444.8f · Cited by 440 · see citing works
Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy
Kong, Y., Tannous, P., Lu, G., Berenji, K., Rothermel, B. A., Olson, E. N., & Hill, J. A. (2006) · Circulation · doi:10.1161/circulationaha.106.625467 · Cited by 377 · see citing works
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
Murdoch, C. E., Zhang, M., Cave, A. C., & Shah, A. M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.016 · Cited by 343 · see citing works
Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
Gan, L., & Johnson, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.011 · Cited by 288 · see citing works
Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes
He, X., Kan, H. J., Cai, L., & Ma, Q. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.007 · Cited by 249 · see citing works
Depression and Cardiovascular Disorders
Whooley, M. A., & Wong, J. M. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185526 · Cited by 241 · see citing works
Uittenbogaard, M. N., & Chiaramello, A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224906 · Cited by 240 · see citing works
Coenzyme Q deficiency triggers mitochondria degradation by mitophagy
Rodríguez-Hernández, Á., Cordero, M. D., Salviati, L., Artuch, R., Pineda, M., Briones, P., Izquierdo, L. G., Cotán, D., Navas, P., & Sánchez-Alcázar, J. A. (2009) · Autophagy · doi:10.4161/auto.5.1.7174 · Cited by 194 · see citing works
Blumenschein, G. R., Kies, M. S., Papadimitrakopoulou, V. A., Lu, C., Kumar, A. J., Ricker, J. L., Chiao, J. H., Chen, C., & Frankel, S. R. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9075-2 · Cited by 167 · see citing works
A mitochondrial bioenergetic basis of depression
Klinedinst, N. J., & Regenold, W. T. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9584-6 · Cited by 153 · see citing works
Amini-Khoei, H., Mohammadi-Asl, A., Amiri, S., Hosseini, M.-J., Momeny, M., Hassanipour, M., Rastegar, M., Haj-Mirzaian, A., Mirzaian, A. H., Sanjarimoghaddam, H., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.022 · Cited by 153 · see citing works
Self-citationIkram, M. A., Park, T. J., Ali, T., & Kim, M. O. (2020) · Antioxidants · doi:10.3390/antiox9090902 · Cited by 150 · see citing works
The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
Zagni, C., Floresta, G., Monciino, G., & Rescifina, A. (2017) · Medicinal Research Reviews · doi:10.1002/med.21437 · Cited by 138 · see citing works
Mitochondria and the economy of stress (mal)adaptation
Morava, É., & Kozicz, T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.005 · Cited by 119 · see citing works
Long-term effects of early life stress exposure: Role of epigenetic mechanisms
Silberman, D. M., Acosta, G. B., & Zubilete, M. A. Z. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.033 · Cited by 104 · see citing works
Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety
Coelho, J. E., Alves, P., Canas, P. M., Valadas, J. S., Shmidt, T., Batalha, V. L., Ferreira, D. G., Ribeiro, J. A., Bader, M., Cunha, R. A., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00067 · Cited by 102 · see citing works
Reduction in podocyte SIRT1 accelerates kidney injury in aging mice
Chuang, P. Y., Cai, W., Li, X., Fang, L., Xu, J., Yacoub, R., He, J. C., & Lee, K. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00255.2017 · Cited by 98 · see citing works
Morris, G., Anderson, G., Berk, M., & Maes, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8477-8 · Cited by 96 · see citing works
Kee, H. J., Bae, E. H., Park, S., et al. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000350148 · Cited by 86 · see citing works
Sadeghi, M., Peeri, M., & Hosseini, M.-J. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.05.017 · Cited by 83 · see citing works
Athira, K. V., Madhana, R. M., Indu Chandran, J. S., Lahkar, M., Sinha, S., & Naidu, V. G. M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.009 · Cited by 81 · see citing works
Liang, E., Liu, X., Du, Z., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9086747 · Cited by 80 · see citing works
Protective Role of Antioxidants in Diabetes-Induced Cardiac Dysfunction
Vassort, G., & Turan, B. (2010) · Cardiovascular Toxicology · doi:10.1007/s12012-010-9064-0 · Cited by 75 · see citing works
Manea, S., Antonescu, M.-L., Fenyo, I. M., Raicu, M., Simionescu, M., & Manea, A. (2018) · Redox Biology · doi:10.1016/j.redox.2018.03.011 · Cited by 75 · see citing works
Sonei, N., Amiri, S., Jafarian, I., Anoush, M., Rahimi-Balaei, M., Bergen, H., Haj‐Mirzaian, A., & Hosseini, M. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1149218 · Cited by 59 · see citing works
Self-citationChen, W.-Y., Zhang, H., Gatta, E., Glover, E. J., Pandey, S. C., & Lasek, A. W. (2019) · Alcohol · doi:10.1016/j.alcohol.2019.02.005 · Cited by 59 · see citing works
Masrour, F. F., Peeri, M., Azarbayjani, M. A., & Hosseini, M. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2519-6 · Cited by 58 · see citing works
Self-citationKar, D., & Bandyopadhyay, A. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492875 · Cited by 51 · see citing works
Gao, W., Wang, W., Zhang, J., Deng, P., Hu, J., Yang, J. M., & Deng, Z. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00443-y · Cited by 49 · see citing works
Ma, W., Yuan, L., Yu, H., Xi, Y., & Xiao, R. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.07.018 · Cited by 46 · see citing works
Mozafari, H., Amiri, S., Mehr, S. E., Momeny, M., Amini-Khoei, H., Bijani, S., & Hosseini, M.-J. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05696-w · Cited by 32 · see citing works
Self-citationErshadi, A. S. B., Amini-Khoei, H., Hosseini, M.-J., & Dehpour, A. R. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03263-8 · Cited by 25 · see citing works
Self-citationLin, F., Tan, Y., He, X., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.546825 · Cited by 15 · see citing works
Abstract 10254: HDAC Inhibition Regulates Cardiac Function via Myofilament Acetylation
Eaton, D., Martin, T. G., Kasa, M., et al. (2021) · Circulation · doi:10.1161/circ.144.suppl_1.10254 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Lv, L.-Z., Wang, Z.-D., Ren, J.-J., Li, L.-H., Liu, X.-B., Li, J.-L., Zhu, H., Jiang, B., Han, Y.-P., Zhou, X.-M., et al. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2025.1722453 · Cited by 7 · see citing works
- Authors
- Nasehi, L., Morassaei, B., Ghaffari, M., Sharafi, A., Dehpour, A. R., & Hosseini, M.-J.
- Affiliations
- Zanjan University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
- Venue
- Canadian Journal of Physiology and Pharmacology
- Publisher
- Canadian Science Publishing
- Published
- 2022-11-01
- Volume
- 100
- Issue
- 11
- Pages
- 1077-1085
- ISSN
- 0008-4212 (ISSN-L)
- 1205-7541
- OpenAlex
- W4297206781
- Cited by
- 5
- References
- 41
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 1
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Canadian Journal of Physiology and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- vorinostat, depression, cardiovascular comorbidity, maternal separation, NADPH oxidase, NOX4, NOX2, mitochondrial biogenesis, PGC-1α, Nrf2, PPARα, heart, fluoxetine, depression-like behavior, gene expression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review